- Home
- BFRI vs BRTX Comparison
BFRI vs BRTX Comparison
Compare BFRI & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- BRTX
- Stock Information
- Founded
- BFRI 1997
- BRTX 1997
- Country
- BFRI United States
- BRTX United States
- Employees
- BFRI N/A
- BRTX N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- BRTX Managed Health Care
- Sector
- BFRI Health Care
- BRTX Health Care
- Exchange
- BFRI Nasdaq
- BRTX Nasdaq
- Market Cap
- BFRI 11.1M
- BRTX 10.0M
- IPO Year
- BFRI 2021
- BRTX N/A
- Fundamental
- Price
- BFRI $0.88
- BRTX $1.28
- Analyst Decision
- BFRI Strong Buy
- BRTX
- Analyst Count
- BFRI 1
- BRTX 0
- Target Price
- BFRI $2.75
- BRTX N/A
- AVG Volume (30 Days)
- BFRI 201.2K
- BRTX 296.1K
- Earning Date
- BFRI 11-12-2025
- BRTX 11-12-2025
- Dividend Yield
- BFRI N/A
- BRTX N/A
- EPS Growth
- BFRI N/A
- BRTX N/A
- EPS
- BFRI N/A
- BRTX N/A
- Revenue
- BFRI $37,164,000.00
- BRTX $383,400.00
- Revenue This Year
- BFRI $9.70
- BRTX $232.67
- Revenue Next Year
- BFRI $12.58
- BRTX $52.92
- P/E Ratio
- BFRI N/A
- BRTX N/A
- Revenue Growth
- BFRI 5.11
- BRTX 1.70
- 52 Week Low
- BFRI $0.54
- BRTX $1.19
- 52 Week High
- BFRI $1.87
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- BFRI 37.83
- BRTX 35.11
- Support Level
- BFRI $0.80
- BRTX $1.24
- Resistance Level
- BFRI $1.13
- BRTX $1.45
- Average True Range (ATR)
- BFRI 0.10
- BRTX 0.09
- MACD
- BFRI -0.03
- BRTX -0.02
- Stochastic Oscillator
- BFRI 16.95
- BRTX 8.89
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.